Mumbai: Ajanta Pharma has worked out an in-licensing agreement with Canadian Prollenium Medical Technologies to exclusively market its dermal filler Revanesse in India.

Prollenium Technologies has its expertise in the area of "medical aesthetics". Revanesse adds volume and smoothens imperfections in the skin, also helping to protect fragile areas of the skin from ageing.

India''s dermatology market is estimated at Rs1,300 crore, according to industry sources.